Patents by Inventor Charles Price Taylor,

Charles Price Taylor, has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Gabapentin for the Treatment of Overactive Bladder, Stress Incontinence and BPH
    Publication number: 20110039899
    Abstract: Use of an alpha-2-delta ligand, or a pharmaceutically acceptable derivative thereof, for the manufacture of a medicament for the treatment of LUTS, other than urinary incontinence, associated with OAB and/or BPH.
    Type: Application
    Filed: August 28, 2008
    Publication date: February 17, 2011
    Inventors: Charles Price Taylor, JR., Andrew John Thorpe, Simon Lemprier Westbrook, David Juergen Wustrow
  • Alpha 2 Delta Ligands for Fibromyalgia and Other Disorders
    Publication number: 20090203782
    Abstract: This invention relates to a method of treating certain disorders by administering a compound of the formula 1 or a pharmaceutically acceptable salt thereof, wherein: R1 is hydrogen, straight or branched alkyl of from 1 to 6 carbon atoms or phenyl; and R2 is straight or branched alkyl of from 4 to 8 carbon atoms, straight or branched alkenyl of from 2 to 8 carbon atoms, cycloalkyl of from 3 to 7 carbon atoms, alkoxy of from 1 to 6 carbon atoms, -alkylcycloalkyl, -alkylalkoxy, -alkyl OH, -alkylphenyl, -alkylphenoxy, or -substituted phenyl. The invention also relates to a method of treating the above disorders by administering the compound (3S,5R)-3-aminomethyl-5-methyl-octanoic acid.
    Type: Application
    Filed: April 20, 2009
    Publication date: August 13, 2009
    Inventors: David James Dooley, Charles Price Taylor, JR., Andrew John Thorpe, David Juergen Wustrow
  • Method of treatment for sexual dysfunction
    Patent number: 7432299
    Abstract: Use of an alpha-2-delta ligand, or a pharmaceutically acceptable derivative thereof, for the manufacture of a medicament for the treatment of premature ejaculation.
    Type: Grant
    Filed: December 2, 2003
    Date of Patent: October 7, 2008
    Assignee: Pfizer Inc.
    Inventors: Charles Price Taylor, Jr., Andrew John Thorpe, Pieter Hadewijn Van Der Graaf, Christopher Peter Wayman, David Juergen Wustrow
  • Alpha 2 Delta Ligands For Fibromyalgia and Other Disorders
    Publication number: 20080207755
    Abstract: This invention relates to a method of treating certain disorders by administering a compound of the formula 1 or a pharmaceutically acceptable salt thereof, wherein: R1 is hydrogen, straight or branched alkyl of from 1 to 6 carbon atoms or phenyl; and R2 is straight or branched alkyl of from 4 to 8 carbon atoms, straight or branched alkenyl of from 2 to 8 carbon atoms, cycloalkyl of from 3 to 7 carbon atoms, alkoxy of from 1 to 6 carbon atoms, -alkylcycloalkyl, -alkylalkoxy, -alkyl OH, -alkylphenyl, -alkylphenoxy, or -substituted phenyl. The invention also relates to a method of treating the above disorders by administering the compound (3S, 5R)-3-aminomethyl-5-methyl-octanoic acid.
    Type: Application
    Filed: April 14, 2008
    Publication date: August 28, 2008
    Inventors: David James Dooley, Charles Price Taylor, Andrew John Thorpe, David Juergen Wustrow
  • Alpha 2 delta ligands for post-traumatic stress disorder
    Patent number: 7381747
    Abstract: This invention relates to a method of treating a disorder selected from OCD, agoraphobia, agoraphobia without history of panic disorder, specific phobia, social phobia, PTSD, restless legs syndrome, premenstrual dysphoric disorder, hot flashes, and fibromyalgia by administering a compound of the formula 1 or a pharmaceutically acceptable salt thereof, wherein: R1 is hydrogen, straight or branched alkyl of from 1 to 6 carbon atoms or phenyl; and R2 is straight or branched alkyl of from 4 to 8 carbon atoms, straight or branched alkenyl of from 2 to 8 carbon atoms, cycloalkyl of from 3 to 7 carbon atoms, alkoxy of from 1 to 6 carbon atoms, -alkylcycloalkyl, -alkylalkoxy, -alkyl OH, -alkylphenyl, -alkylphenoxy, or -substituted phenyl. The invention also relates to a method of treating the above disorders by administering the compound (3S,5R)-3-Aminomethyl-5-methyl-octanoic acid.
    Type: Grant
    Filed: September 7, 2006
    Date of Patent: June 3, 2008
    Assignee: Warner-Lambert Company LLC
    Inventors: David James Dooley, Charles Price Taylor, Jr., Andrew John Thorpe, David Juergen Wustrow
  • Alpha2delta ligands for fibromyalgia and other disorders
    Patent number: 7164034
    Abstract: This invention relates to a method of treating a disorder selected from OCD, agoraphobia, agoraphobia without history of panic disorder, specific phobia, social phobia, PTSD, restless legs syndrome, premenstrual dysphoric disorder, hot flashes, and fibromyalgia by administering a compound of the formula 1 or a pharmaceutically acceptable salt thereof, wherein: R1 is hydrogen, straight or branched alkyl of from 1 to 6 carbon atoms or phenyl; and R2 is straight or branched alkyl of from 4 to 8 carbon atoms, straight or branched alkenyl of from 2 to 8 carbon atoms, cycloalkyl of from 3 to 7 carbon atoms, alkoxy of from 1 to 6 carbon atoms, -alkylcycloalkyl, -alkylalkoxy, -alkyl OH, -alkylphenyl, -alkylphenoxy, or -substituted phenyl. The invention also relates to a method of treating the above disorders by administering the compound (3S,5R)-3-Aminomethyl-5-methyl-octanoic acid.
    Type: Grant
    Filed: December 12, 2003
    Date of Patent: January 16, 2007
    Assignee: Pfizer Inc.
    Inventors: David James Dooley, Charles Price Taylor, Jr., Andrew John Thorpe, David Juergen Wustrow
  • Anti-inflammatory method using gamma-aminobutyric acid (GABA) analogs
    Patent number: 6887902
    Abstract: GABA analogs such as gabapentin and pregabalin are useful to prevent and treat inflammatory diseases.
    Type: Grant
    Filed: August 8, 2001
    Date of Patent: May 3, 2005
    Assignees: Warner-Lambert Company, Board of Regents of the University of Texas System
    Inventors: Denis Schrier, Charles Price Taylor, Jr., Karin Nanette Westlund High
  • Alpha2delta ligands for fibromyalgia and other disorders
    Publication number: 20040186177
    Abstract: This invention relates to a method of treating a disorder selected from OCD, agoraphobia, agoraphobia without history of panic disorder, specific phobia, social phobia, PTSD, restless legs syndrome, premenstrual dysphoric disorder, hot flashes, and fibromyalgia by administering a compound of the formula 1 1
    Type: Application
    Filed: December 12, 2003
    Publication date: September 23, 2004
    Inventors: David James Dooley, Charles Price Taylor, Andrew John Thorpe, David Juergen Wustrow
  • Gabapentin analogues for fibromy algia and concomitant disorders
    Publication number: 20040180959
    Abstract: This invention provides new uses for compounds of formula 1
    Type: Application
    Filed: December 12, 2003
    Publication date: September 16, 2004
    Inventors: David James Dooley, Charles Price Taylor, Andrew John Thorpe, David Juergen Wustrow
  • Method of treatment
    Publication number: 20040180958
    Abstract: Use of an alpha-2-delta ligand, or a pharmaceutically acceptable derivative thereof, for the manufacture of a medicament for the treatment of LUTS, other than urinary incontinence, associated with OAB and/or BPH.
    Type: Application
    Filed: December 10, 2003
    Publication date: September 16, 2004
    Inventors: Charles Price Taylor, Andrew John Thorpe, Simon Lemprier Westbrook, David Juergen Wustrow
  • Method of treatment for sexual dysfunction
    Publication number: 20040176456
    Abstract: Use of an alpha-2-delta ligand, or a pharmaceutically acceptable derivative thereof, for the manufacture of a medicament for the treatment of premature ejaculation.
    Type: Application
    Filed: December 2, 2003
    Publication date: September 9, 2004
    Inventors: Charles Price Taylor, Andrew John Thorpe, Pieter Hadewijn Van Der Graaf, Christopher Peter Wayman, David Juergen Wustrow
  • Therapeutic use of alpha-2-delta ligands
    Publication number: 20040143014
    Abstract: The instant invention relates to the use of an alpha-2-delta ligand in the treatment of chronic obstructive pulmonary disease (COPD) and diseases associated with a diagnosis of COPD, and particularly to the treatment of chronic cough, which may be unrelated to COPD.
    Type: Application
    Filed: December 12, 2003
    Publication date: July 22, 2004
    Applicant: Pfizer Inc
    Inventors: Claude Philippe Bertrand, Maria Emilia Pereira Chicau Chovet, Pierangelo Geppetti, Charles Price Taylor, Andrew John Thorpe, David Juergen Wustrow
  • Alpha2delta ligands for the treatment of fibromyalgia and other disorders
    Publication number: 20040138305
    Abstract: The invention relates to a method of treating fibromyalgia and other disorders in a mammal by administering a compound compound of Formula I 1
    Type: Application
    Filed: December 9, 2003
    Publication date: July 15, 2004
    Inventors: Charles Price Taylor, Andrew John Thorpe, Fong Wang, David Juergen Wustrow
  • Pharmaceutical uses for alpha2delta ligands
    Publication number: 20040132636
    Abstract: The invention relates to a method of treating central nervous system disorders and other disorders by administering an alpha2delta ligand such as, for example, a compound of the formula 1
    Type: Application
    Filed: December 9, 2003
    Publication date: July 8, 2004
    Inventors: David James Dooley, Charles Price Taylor, Andrew John Thorpe, Fong Wang, David Juergen Wustrow
  • Combinations of an alpha-2-delta ligand with a selective inhibitor of cyclooxygenase-2
    Publication number: 20030199567
    Abstract: The invention relates to a combination, comprising a selective inhibitor of COX-2, or a pharmaceutically acceptable salt thereof, and an Alpha-2-delta ligand, or a pharmaceutically acceptable salt thereof, and valdecoxib. Examples of selective inhibitors of COX-2 include valdecoxib, rofecoxib, and celecoxib. Examples of Alpha-2-delta ligands include gabapentin, pregabalin, (3S,4S)-(1-Aminomethyl-3,4-dimethyl-cyclopentyl)-acetic acid, and 3-(1-aminomethyl-cyclohexylmethyl)-4H-[1,2,4]oxadiazol-5-one hydrochloride. The combinations are useful for treating certain diseases including cartilage damage, inflammation, pain, and arthritis.
    Type: Application
    Filed: February 14, 2003
    Publication date: October 23, 2003
    Inventor: Charles Price Taylor
  • Method for preventing and treating alcoholism
    Patent number: 6426368
    Abstract: GABA analogs are useful to prevent and treat gastrointestinal damage and ethanol withdrawal syndrome. Preferred treatments employ gabapentin or pregabalin.
    Type: Grant
    Filed: March 13, 2001
    Date of Patent: July 30, 2002
    Assignees: Warner-Lambert Company, University of Oklahoma
    Inventors: Lionel Bueno, Maria Chovet, Laurent Diop, Antonio Guglietta, Hilary J. Little, Michael Francis Rafferty, Jiayuan Ren, Charles Price Taylor, Jr., William Patrick Watson
  • Method for treating asthma using pregabalin
    Publication number: 20020058706
    Abstract: This invention relates to a method for preventing asthma and related inflammatory disease in mammals. This invention also relates to a method for treating or alleviating the symptoms of asthma and related inflammatory disease in mammals.
    Type: Application
    Filed: September 14, 2001
    Publication date: May 16, 2002
    Inventors: Denis J. Schrier, Charles Price Taylor
  • Anti-inflammatory method
    Publication number: 20020032235
    Abstract: GABA analogs such as gabapentin and pregabalin are useful to prevent and treat inflammatory diseases.
    Type: Application
    Filed: August 8, 2001
    Publication date: March 14, 2002
    Inventors: Denis Schrier, Charles Price Taylor, Karin Nanette Westlund High
  • Use of GABA analogs such as Gabapentin in the manufacture of a medicament for treating inflammatory diseases
    Patent number: 6329429
    Abstract: GABA analogs such as gabapentin and pregabalin are useful to prevent and treat inflammatory diseases.
    Type: Grant
    Filed: October 25, 1999
    Date of Patent: December 11, 2001
    Assignee: Warner-Lambert Company
    Inventors: Denis Schrier, Charles Price Taylor, Jr., Karin Nanette Westlund High
  • Method for preventing and treating alcoholism
    Publication number: 20010014698
    Abstract: GABA analogs are useful to prevent and treat gastrointestinal damage and ethanol withdrawal syndrome. Preferred treatments employ gabapentin or pregabalin.
    Type: Application
    Filed: March 13, 2001
    Publication date: August 16, 2001
    Inventors: Lionel Bueno, Maria Chovet, Laurent Diop, Antonio Guglietta, Hilary J. Little, Michael Francis Rafferty, Jiayuan Ren, Charles Price Taylor,, W. P. Watson